DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 03 · Volume 64 · November 1990 DOI: 10.1055/s-008-40439

Review Article

331

Original Article

340
Takahashi, Hoyu; Tatewaki, Wataru; Wada, Ken; Niwano, Hiroe; Shibata, Akira: Fibrinolysis and Fibrinogenolysis in Disseminated Intravascular Coagulation
349
Mitropoulos, K A; Martin, J C; Burgess, A I; Esnouf, M P; Stirling, Y; Howarth, D J; Reeves, B E A: The Increased Rate of Activation of Factor XII in Late Pregnancy Can Contribute to the Increased Reactivity of Factor VII
358
Cattaneo, Marco; Tenconi, Paola M; Alberca, Ignazio; Garcia, Vicente Vicente; Mannucci, Pier Mannuccio: Subcutaneous Desmopressin (DDAVP) Shortens the Prolonged Bleeding Time in Patients with Liver Cirrhosis
361
Gilabert, Juan; Estellés, Amparo; Aznar, Justo; España, Francisco; Andrés, Cristina; Santos, Teresa; Vallés, Juana: Contribution of Platelets to Increased Plasminogen Activator Inhibitor Type 1 in Severe Preeclampsia
361
Nanninga, P B; van Teunenbroek, A; Veenhof, C H N; Büller, H R; ten Cate, J W: Low Prevalence of Coagulation and Fibrinolytic Activation in Patients with Primary Untreated Cancer
367
Rostrup, Morten; Mundal, Håvard Holth; Kjeldsen, Sverre Erik; Gjesdal, Knut; Eide, Ivar: Awareness of High Blood Pressure Stimulates Platelet Release Reaction
383
Catalano, Maria; Russo, Umberto; Belletti, Sebastiano; Colombo, Fabrizio; Belloni, Armando; Rosso, Gianfranco del; Lombardi, Federico; Libretti, Arnaldo: β-TG and Plasma Catecholamines Levels after Sympathetic Stimuli in Hypertensives and Patients with Peripheral Vascular Disease
386
Davis, Hugh M; Brown, Susan K; Nash, David W; Pennetti, Aniello M; Salzman, Phyllis M; Schreiber, Alian B; Haimovich, Joseph: Lack of Immune Response to Mouse IgG in Hemophilia A Patients Treated Chronically with Monoclate®, a Monoclonal Antibody Affinity Purified Factor VIII Preparation
390
Binnema, D J; Dooijewaard, G; van Iersel, J J L; Turion, P N C; Kluft, C: The Contact-System Dependent Plasminogen Activator from Human Plasma: Identification and Characterization
407
George, F; Pourreau-Schneider, N; Boutiere, B; Arnoux, D; Boutiére, B; Berthois, Y; Martin, P M; Sampol, J: Concomitant Secretion by A431 Cells of Tissue Plasminogen Activator and a Specific Inhibitor Masks EGF Modulation of tPA Activity
412
413
Chung, Amy; Ofosu, Frederick A; Blajchman, Morris A: The Antithrombotic Properties of Human Prothrombin Fragment 1.2 in Mice
426
Abercrombie, David M; Buchinski, Bruce; Salvato, Kathleen A; Vovis, Gerald F; Stump, David C; Broeze, Robert J: Fibrin Specific Thrombolysis by Two-Chain Urokinase-Type Plasminogen Activator Cleaved after Arginine 156 by Thrombin
438
Voytik, Sherry; Badylak, Stephen F; Burke, Sandra; Klabunde, Richard E; Henkin, Jack; Simmons, Abby: The Protective Effect of Heparin in a Dog Model of Rethrombosis Following Pharmacologic Thrombolysis
445
Mao, Simon J T; Rechtin, Ann E; Krstenansky, John L; Jackson, Richard L: Characterization of a Monoclonal Antibody Specific to the Amino Terminus of the α-Chain of Human Fibrin
445
Senatore, F; Shankar, H; Ho, C H; Avantsa, S; Allon, M; Posteraro, R: Effect of Soluble and Immobilized Plasmin on Fibrinogen and Platelets
449
Maruyama, M; Kamiguti, Aura S; Cardoso, J L C; Sano-Martins, Ida S; Chudzinski, Ana M; Santoro, M L; Morena, P; Tomy, Sandra C; Antonia, Luci C; Mihara, H; Kelen, Eva M A: Studies on Blood Coagulation and Fibrinolysis in Patients Bitten by Bothrops jararaca (jararaca)
464
Wilhelm, James; Kalyan, Narender K; Lee, Shaw Guang; Hum, Wah-Tung; Rappaport, Ruth; Hung, Paul P: Deglycosylation Increases the Fibrinolytic Activity of a Deletion Mutant of Tissue-Type Plasminogen Activator
472
Gris, J C; Schved, J F; Raffanel, C; Dubois, A; Aguilar-Martinez, P; Arnaud, A; Sanchez, N; Sarlat, C; Balmès, J L: Impaired Fibrinolytic Capacity in Patients with Inflammatory Bowel Disease
473
Chen, Shih-Luen; Yang, Wu-Chang; Huang, Tung-Po; Wann, Shiang; Teng, Che-ming: Chlorobutanol, a Preservative of Desmopressin, Inhibits Human Platelet Aggregation and Release In Vitro
476
Giles, Alan R; Nesheim, Michael E; Herring, Steven W; Hoogendoorn, Hugh; Stump, David C; Heldebrant, Charles M: The Fibrinolytic Potential of the Normal Primate following the Generation of Thrombin In Vivo
482
Larsson, P T; Wiman, B; Olsson, G; Angelin, B; Hjemdahl, P: Influence of Metoprolol Treatment on Sympatho-Adrenal Activation of Fibrinolysis
488
Kovensky, J; Sassetti, B; Fernández Cirelli, A; Kordich, L: Low Anticoagulant Activity of High Sulphated Heparan Sulphates
493
Rucinski, Boguslaw; Niewiarowski, Stefan; Strzyzewski, Marian; Holt, John C; Mayo, Kevin H: Human Platelet Factor 4 and Its C-Terminal Peptides: Heparin Binding and Clearance from the Circulation
499
Electricwala, A; Irons, L; Wait, R; Carr, R J G; Ling, R J; Grossenbacher, H; Atkinson, T: Physico-Chemical Properties of Recombinant Desulphatohirudin
510
Owens, Charlene K; Mclntire, Larry V; Lasslo, Andrew: Ethanol Inhibition of Thrombus Formation on Collagen-Coated Glass

Original Articles

505
Mätzsch, Thomas; Bergqvist, David; Hedner, Ulla; Nilsson, Bo; Østergaar, Per: Effects of Low Molecular Weight Heparin and Unfragmented Heparin on Induction of Osteoporosis in Rats

Scientific and Standardization Committee Communications

Letter to the Editor

485
Grodzinska, Lilia; Hafner, Gerd; Darius, Harald; Medizinische Klinik, II: Effest of Molsidomine on t-PA and PAI Activity in Man: A Double Blind, Placebo Controlled Study
486
O’Brien, J R; Ethwrington, M D: How Much Aspirin?
487
Maschio, Aldo Del; Bazzoni, Gianfranco; Bertelá, Vittorio: Investigation of Platelet/Leukocyte Interaction by Whole Blood Aggregometry
488
Lionnet, F; Gouault-Heilmann, M; Azoulay, C; Lacorte, J M; Schaeffer, A: Auto-lmmune Eactor Vlll : G lnhibitor Durably Responsive to lmmunoglobulin: A New Case
525
Rafanelli, Daniela; Grossi, Alberto; Vannucchi, Alessandro M; Cinotti, Sandro; Morfini, Massimo; Ferrini, Pierluigi Rossi: The Effect of Picotamide on Platelet Function in Patients with Myeloproliferative Disorders
527
Sampietro, M; Yang, X Y; Sacchi, E; Mannucci, P M: Restriction of Polymerase Chain Reaction Products for Carrier